IM Cannabis EBIT Margin 2021-2025 | IMCC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

IM Cannabis ebit margin from 2021 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

IM Cannabis ebit margin from 2021 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$229.7B
Boston Scientific (BSX)	$154.4B
Stryker (SYK)	$149.4B
EssilorLuxottica (ESLOY)	$132.1B
Medtronic (MDT)	$115.1B
Lonza Group Ag (LZAGY)	$49.6B
Haleon (HLN)	$44.5B
ResMed (RMD)	$37.3B
Agilent Technologies (A)	$34.1B
GE HealthCare Technologies (GEHC)	$34.1B
Terumo (TRUMY)	$24.5B
Koninklijke Philips (PHG)	$23.1B
Insulet (PODD)	$20.6B
Zimmer Biomet Holdings (ZBH)	$18.6B
Baxter (BAX)	$14.6B
Smith & Nephew SNATS (SNN)	$13.2B
Demant (WILYY)	$8.6B
Sunny Optical Technology (SNPTF)	$8.6B
Bio-Rad Laboratories (BIO)	$6.8B
Lantheus Holdings (LNTH)	$5.7B
Prestige Consumer Healthcare (PBH)	$3.8B
Perrigo (PRGO)	$3.8B
Haemonetics (HAE)	$3.7B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
ICU Medical (ICUI)	$3.2B
QuidelOrtho (QDEL)	$2B
LeMaitre Vascular (LMAT)	$1.9B
AtriCure (ATRC)	$1.5B
Acuren (TIC)	$1.5B